Trial NCT01467492

View at ClinicalTrials.gov 
Org. Study IDs: VX11-950-116

Last trial update was posted on 2015-08-03

MeSH Interventions

Interferon alpha-2 Interferon-alpha Interferons Peginterferon alfa-2a Ribavirin

MeSH Conditions

Hepatitis Hepatitis A Hepatitis C Hepatitis C, Chronic

Other Conditions


Stopping Reasons

It was decided by Sponsor on 13 January 2014 to terminate study early at primary efficacy endpoint as part of a decision to modify drug development plan.

Limitations And Caveats

It was decided by Sponsor on 13 January 2014 to terminate the study early as part of a decision to modify the drug development plan. Eligible participants completed virologic follow-up after termination.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID